Vaccinex shareholders elect directors, ratify auditor at annual meeting

VACCINEX, INC.

Elected Gerald E. Van Strydonck and Barbara Yanni as directors for three-year terms ending 2026.
Van Strydonck received 26,745,493 votes for and 213,769 withheld; Yanni 26,763,394 for and 195,868 withheld.
Ratified Deloitte & Touche LLP as independent auditor for FY2023 with 34,406,314 for, 108,269 against, 83,727 abstentions.
Broker non-votes on director election were 7,639,048 for each nominee.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

VACCINEX, INC. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-05-11 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-05-11

Exact text from the filing

The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. Votes For Votes Against Votes Abstained 34,406,314 108,269 83,727

View on SEC.gov

Browse all shareholder votes →

VACCINEX, INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-142882

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.